Among bone metabolic disturbances, ALP elevation was detected for the first time in 1996, and since then other new cases with hypophosphatemia, low serum calcium and 1,25-dihydroxycholecalciferol and PTH elevation have been identified. This evidence concerns the gene PTH and hypophosphatemia.